Who should read this notice: All healthcare professionals, especially those utilizing telemedicine services Owners, operators and managers of laboratories and/or other testing and treatment facilities Pharmacies and other medical... Read More
The last few years have brought on a slew of litigation aimed at combatting the opioid epidemic. Most recently, however, a complaint has been lodged against the United States, which has great potential to shape future litigation. Specifically, on... Read More
In a recent trend, the government is increasing investigations and prosecutions of pharmacies alleging health care fraud and False Claims Act (“FCA”) violations based on inventory shortages. Multiple governmental offices, including the... Read More
Frier Levitt Co-Founding Partner Daniel B. Frier recently summarized a variety of ways in which providers can become ensnarled in fraudulent schemes disguised as legitimate business models. Since the publication of that article, a significant... Read More
On September 9, 2020, the Justice Department (DOJ) announced a 77-year old and 65-year old were sentenced to 28-months and 24-months, respectively, for their part in a compounded medication scheme that cost the TRICARE program $65 million in actual... Read More
